CMLase
Productby Revel Pharmaceuticals
Heard in 2 episodes across 1 show since Jul 2026
CMLase is an engineered enzyme designed to break down carboxymethyl-lysine (CML), a sugar-derived protein cross-linking product associated with tissue aging and disease.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 2 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
| Nov 2026 | 0 |
Email alert
Email me when CMLase comes up on a podcast
One email a week at most, with the new episodes that mention CMLase. Free, no account needed, unsubscribe in one click.
What experts have said about CMLase
1 statement · 1 positive
CMLase reversed accumulated glycation damage in elderly human tissue samples.
“reversing damage that accumulated over the lifetime”
Open the episode · Mira Murati's 975B Open Model, Ramin Hasani on Post-Transformer AI, and Demis' AI FINRA | EP #271Listen at 1:53:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring CMLase, newest first